Captrust Financial Advisors Lensar, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$6.15 - $7.94 $430 - $555	-70 Reduced 31.11%	155 $1,000
Q1 2022 May 16, 2022	BUY	$5.8 - $8.2 $435 - $615	75 Added 50.0%	225 $2,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $8.66 $357 - $450	-52 Reduced 25.74%	150 $1,000
Q1 2021 May 17, 2021	BUY	$6.28 - $9.56 $1,205 - $1,835	192 Added 1920.0%	202 $1,000
Q4 2020 Feb 16, 2021	BUY	$6.7 - $12.2 $67 - $122	10 New	10 $0

4.83M

500

49K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $48.9M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.